z-logo
open-access-imgOpen Access
Impulse Control Disorders by Dopamine Partial Agonists: A Pharmacovigilance-Pharmacodynamic Assessment Through the FDA Adverse Event Reporting System
Author(s) -
Michele Fusaroli,
Emanuel Raschi,
Valentina Giunchi,
Marco Menchetti,
Roberto Rimondini,
Fabrizio De Ponti,
Elisabetta Poluzzi
Publication year - 2022
Publication title -
the international journal of neuropsychopharmacology
Language(s) - English
Resource type - Journals
eISSN - 1469-5111
pISSN - 1461-1457
DOI - 10.1093/ijnp/pyac031
Subject(s) - pharmacovigilance , adverse event reporting system , impulse control , adverse effect , pharmacodynamics , medicine , pharmacology , dopamine , pharmacokinetics , psychiatry

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom